Evidence map›Paper›PMID 28062199›Full record

ReviewMolecular and cellular endocrinology2017

MicroRNAs and the metabolic hallmarks of aging.

Berta Victoria, Yury O Nunez Lopez, Michal M Masternak

Open access · greenAbstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Molecular Morbidity Score-Can MicroRNAs Assess the Burden of Disease?International journal of molecular sciences · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. microRNA-449a reduces growth hormone-stimulated senescent cell burden through PI3K-mTOR signaling.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. The Aging Process: A Metabolomics Perspective.Molecules (Basel, Switzerland) · 2022
    Article
  12. Review
  13. Dietary regulation in health and disease.Signal transduction and targeted therapy · 2022
    Review
  14. Review
  15. New Directions in Research on Aging.Stem cell reviews and reports · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Berta VictoriaBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 6900 Lake Nona Blvd., Orlando, FL 32827, USA. Electronic address: Berta.VictoriaMartinez@ucf.edu.
Yury O Nunez LopezTranslational Research Institute for Metabolism & Diabetes. Florida Hospital, 301 East Princeton St, Orlando, FL 32804, USA. Electronic address: Yury.Nunez-Lopez@flhosp.org.
Michal M MasternakBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 6900 Lake Nona Blvd., Orlando, FL 32827, USA; Department of Head and Neck Surgery, The Greater Poland Cancer Centre, 15 Garbary St., 61-866, Poznan, Poland. Electronic address: Michal.Masternak@ucf.edu.
University of Central Florida · USTranslational Research Institute for Metabolism and Diabetes · US

Funding

Dietary fat, visceral fat depots and agingR01AG032290 · NIA · UNIVERSITY OF CENTRAL FLORIDA · PI MASTERNAK, MICHAL MATEUSZ · 2010 to 2014
$1.5M
NIA NIH HHS R01 AG032290
6 · The paper itself

Abstract

Aging, the natural process of growing older, is characterized by a progressive deterioration of physiological homeostasis at the cellular, tissue, and organismal level. Metabolically, the aging process is characterized by extensive changes in body composition, multi-tissue/multi-organ insulin resistance, and physiological declines in multiple signaling pathways including growth hormone, insulin/insulin-like growth factor 1, and sex steroids regulation. With this review, we intend to consolidate published information about microRNAs that regulate critical metabolic processes relevant to aging. In certain occasions we uncover relationships likely relevant to aging, which has not been directly described before, such as the miR-451/AMPK axis. We have also included a provocative section highlighting the potential role in aging of a new designation of miRNAs, namely fecal miRNAs, recently discovered to regulate intestinal microbiota in mammals.

Indexed as

AgingAMP-Activated Protein KinasesAnimalsBody CompositionGastrointestinal MicrobiomeGene Expression Regulation, DevelopmentalGonadal Steroid HormonesGrowth HormoneHomeostasisHumansInsulinInsulin-Like Growth Factor IInsulin ResistanceMicroRNAsSignal TransductionSymbiosisAMP-Activated Protein KinasesGonadal Steroid HormonesGrowth HormoneIGF1 protein, humanInsulinInsulin-Like Growth Factor IMicroRNAsAgingInflammationMetabolismMicrobiomemiRNAMitochondria

Identifiers

PMID28062199
PMCPMC5724961
OpenAlexW2568548662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.